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Highly exfoliated sulfonated graphene sheets (SGSs), an alternative to graphene oxide and graphene derivatives,
were synthesized, characterized, and applied to liver cancer cells in vitro. Cytotoxicity profiles were obtained using
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, WST-1[2-(4-iodophenyl)-3-(4-nitrophenyl)-5-
(2,4-disulfophenyl)-2H-tetrazolium, and lactate dehydrogenase release colorimetric assays. These particles were
found to be non-toxic across the concentration range of 0.1 to 10 μg/ml. Internalization of SGSs was also
studied by means of optical and electron microscopy. Although not conclusive, high-resolution transmission
and scanning electron microscopy revealed variant internalization behaviors where some of the SGS became
folded and compartmentalized into tight bundles within cellular organelles. The ability for liver cancer cells to
internalize, fold, and compartmentalize graphene structures is a phenomenon not previously documented for
graphene cell biology and should be further investigated.
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Carbon-derived nanoparticles (NPs) such as single- and
multi-walled carbon nanotubes, fullerenes, and graphene
are all receiving attention because of their interesting and
unusual electronic [1], thermal [2], and mechanical [3] pro-
perties. We have recently demonstrated a facile route to-
wards the synthesis of nanosized water-soluble sulfonated
graphene sheets (SGSs) that use graphite as the starting
material [4]. This method relies on the addition of phenyl
radicals with subsequent sulfonation of the phenyl groups
and produces fewer defects and holes that can be intro-
duced into the graphene plates through the use of heavy
sonication. A possible application of these SGSs is within
the medical sector due to their enhanced solubility (com-
pared to other graphene derivatives) and potential for sur-
face modifications for attachment of biomolecules and* Correspondence: scurley@mdanderson.org
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in any medium, provided the original work is pdrugs. However, the interaction of SGSs with biological sys-
tems has yet to be investigated and is the basis of the work
described herein.
To date, much of the biological work regarding gra-
phene has focused on assessing the cytotoxicity, cell
adhesion, proliferation, and antibacterial properties of
graphene oxide (GO) [5-8] as well as biodistribution, to-
xicology, and internalization of various suspensions of GO
complexes. These include 125I and 188Re radioisotope-
labeled GO [9,10], PEGylated GO for cellular imaging and
delivery of water-insoluble cancer drugs [11-13], and the
imaging and treatment of brain, lung, and breast xenograft
tumors in mice through the use of photothermal light
therapy from the absorption of near-infrared (NIR) light
by PEGylated GO with fluorescent Cy7 probes [14].
Toxicity analysis (in vitro) of GO (prepared using chem-
ical vapor deposition or the modified Hummers method
[15]) on lung [16,17] and neuronal [18] cell lines (A549 and
PC12, respectively) has shown concentration-dependent
cytotoxicity. The exact mechanism of cell death from GO
remains uncertain although a slight increase in lactate
dehydrogenase (LDH) from cells, generation of reactiveOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Corr et al. Nanoscale Research Letters 2013, 8:208 Page 2 of 10
http://www.nanoscalereslett.com/content/8/1/208oxygen species, and weak activation of a caspase-3-medi-
ated apoptosis pathway have all been reported. These re-
ports suggest GO cytotoxicity from either direct cellular
membrane damage or activation of natural cellular suicide
mechanisms.
Similarly, in vivo mouse toxicology studies have shown
that GO nanoplatelets of diameters 10 to 700 nm appar-
ently cause no acute toxicities at low doses [9,10]. How-
ever, at high doses (10 mg/kg), significant pathological
changes such as granulomatous lesions, pulmonary
edema, inflammatory cell infiltration, and fibrosis were
observed throughout the lungs.
In light of the potential applications of graphene materials
in drug delivery, imaging, and thermal therapy, but with
limitations due to cytotoxicity of GO, we sought to investi-
gate the in vitro interaction of our highly water-soluble SGS
with liver cancer cells. Our initial studies using the standard
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium brom-
ide (MTT), WST-1[2-(4-iodophenyl)-3-(4-nitrophenyl)-5-
(2,4-disulfophenyl)-2H-tetrazolium (WST-1), and LDH
colorimetric assays have shown that SGSs are non-toxic up
to concentrations of 10 μg/ml. We also show that liver can-
cer cell lines (SNU449 and Hep3B) can internalize SGSs of
diameters up to 5 μm, which in some cases are comparable
to the size of the cells themselves. Preliminary electron mi-
croscopy analysis also suggests that these cells are capable
of folding and compartmentalizing sheets of smaller sizes
(approximately 1.41 μm) although more work should be
undertaken to validate.
Since graphene has been documented to be the hardest
material known [3], this unique behavior of water-soluble
SGS with cells is counterintuitive and suggests a novel
finding that may have far-reaching applications in biology
and medicine such as enhanced drug delivery (due to the
large graphene surface area), and should warrant further
investigation. Given that these SGSs are non-toxic up to
10 μg/ml, we feel they can be used as an adequate scaffold
to simultaneously attach targeting moieties such as EGFR
antibodies (e.g., cetuximab, C225) and chemo-agents such
as doxorubicin and gemcitabine in a bid to treat hepato-
cellular carcinoma legions. The use of a targeted thermal
‘trigger’ such as photon activation (i.e., NIR light) or ra-
diofrequency electric fields could allow these SGSs to re-
lease their cargo into the cells upon irradiation by a
stimuli. Such a scheme has recently been reported using
cisplatin-filled ultra-short carbon nanotubes that release
their cargo upon exposure to high-intensity radiofrequen-
cy electric fields [19].
Methods
Sample preparation and characterization
Samples were obtained from Mukherjee et al. [4]. In their
technique, highly exfoliated SGSs can be synthesized by
sulfonation of commercially available graphite (particlesize < 20 μm) in oleum to overcome the cohesive van deer
Waals attractions between adjacent sheets. Their exfoli-
ation method was selected over the procedure by Si et al.
[20] as it produces fewer defects and holes that can be in-
troduced into the graphene plates through the use of
heavy sonication. In brief, the addition of benzoyl peroxide
to a suspension of graphite in benzene at 75°C to 80°C
provided phenylated graphite, the sulfonation of which by
oleum leads to highly-exfoliated graphene sheets which
can be further converted into a sodium salt by the ad-
dition of 1 M sodium hydroxide. This material, in powder
form, is highly soluble in water (approximately 2.1 mg/ml)
due to the p-sulphonated substituents, and it is relatively
free of basal plane defects that typically result from the
removal of the oxygen functionality of comparable GO
compounds.
The SGSs in powder form were characterized via Raman
spectroscopy, thermogravimetric analysis (TGA), X-ray
photoelectron spectroscopy (XPS), and atomic force mi-
croscopy (AFM). Raman spectra of the initial graphite ma-
terial were compared to SGSs using a Renishaw 1000
micro-Raman system (Gloucestershire, UK) with a 514-nm
excitation laser source. Multiple spectra were taken [3-5]
and normalized to the G band. TGA data were taken using
a model SDT 2960 TA (TA Instruments, Newcastle, DE,
USA) instrument in both an argon and air atmosphere.
Samples were first degassed at 80°C and then heated at
10°C/min to 700°C and held there for 20 min. This al-
lowed for accurate percentage determination of the so-
dium sulfonate groups (approximately 6%). XPS data were
obtained using a physical electronics (PHI QUENTERA,
Chanhassen, MN, USA) XPS/ESCA system with a base
pressure of 5 × 10−9 Torr. A monochromatic Al X-ray
source at 100 W was used with a pass energy of 26 eV and
a 45° takeoff angle. The beam diameter was 100.0 μm.
Low- and high-resolution survey scans of the elements
C, O, Na, and S were taken. At least two separate loca-
tions were analyzed for each sample. For AFM studies,
aqueous solution of SGSs at 50 mg/l was drop-cast onto
freshly cleaved mica and placed in a desiccator for 24 h
prior to imaging. Tapping-mode AFM images were taken
in air under ambient conditions on a Digital Instruments
Nanoscope IIIA (Digital Instruments, Tonawanda, NY,
USA).
Cell culture studies
SGS cytotoxicity was investigated using multiple assays.
Cell membrane integrity was evaluated using a LDH re-
lease assay. Cell proliferation/metabolic activity was inves-
tigated using the popular MTT and WST-1 colorimetric
assays. For in vitro experiments, approximately 3 mg of
the SGS powder was added to 3 ml of phosphate-buffered
saline (PBS) to create two suspensions of concentration
1,000 μg/ml. All samples were sterilized for 20 min using
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cer cells were utilized for the experiments (American Type
Culture Collection, Bethesda, MD, USA). The cells were
maintained in standard culture conditions with 10% fetal
calf serum and penicillin/streptomycin at 37°C. Cell
morphology was analyzed using real-time bright-field op-
tical imaging.
MTT assay
SNU449 and Hep3B cells were plated in 96-well plates
at a density between 1,000 to 2,000 cells per well. After
24 h, the SNU449 and Hep3B cells were exposed to in-
creasing concentrations (0.1, 1.0, 10, and 100 μg/ml) of
SGSs in PBS and were compared to a PBS only control
group (all suspensions were lightly sonicated for 5 min
before use). Cell viability was assessed at 24, 72, and 120 h
after exposure to the SGSs. At each time point, the media
(100 μl) was carefully aspirated and replaced before adding
MTT reagent to each well and incubating for 4 h. The
media was again carefully removed, and purple formazan
crystals were dissolved in dimethyl sulfoxide (DMSO).
The 96-well plates were then spun down at 3,500 rpm for
5 min (to force any cells/SGS debris to the bottom of the
well) where 50 μl of the colored media was withdrawn
and placed into a fresh 96-well plate. Absorbance was
interpreted at 570 nm for each well using a SPECTROstar
Nano plate reader (BMG Labtech Inc., Cary, NC, USA).
WST-1 assay
These studies were prepared similar to the MTT assay
but for a shorter duration (24, 48, and 72 h) as MTT as-
says showed that maximum toxicity occurred at 72 h.
Also, it was harder to keep the control cells from over-
growing for times greater than 72 h. At each time point,
WST-1 reagent was added to each well and incubated
for 3 h. The 96-well plate was then spun down at 3,500
rpm for 5 min (to force any cells/SGS debris to the bot-
tom of the well) where 50 μl of the colored media was
withdrawn and placed into a fresh 96-well plate. This
negated any effects from inherent SGS absorption as all
the SGSs were contained at the bottom of the discarded
well. Absorbance was interpreted at 450 nm for each
well using a SPECTROstar Nano plate reader (BMG
Labtech Inc.).
LDH assay
SNU449 and HEP3B cells were exposed to various con-
centrations of SGSs (0.1, 1.0, 10.0, and 100 μg/ml) for 24,
48, and 72 h, and the cell-free supernatant was removed.
Maximum LDH release was obtained by exposing the cells
to a 2% Triton-X 100 solution to permeabilize the mem-
branes. LDH activity was determined by the use of a cyto-
toxicity detection kit purchased from Roche Applied
Science (Indianapolis, IN, USA). Aliquots of the cellculture media from the SGS-exposed samples, untreated
samples, and the permeabilized samples were added to a
96-well plate, and an equal volume of LDH cytotoxicity
detection reagent was added. The 96-well plates were read
on a spectrophotometer, and the absorbance at 492 nm
was measured. Calculations were performed as per the
recommendations of the kit. To show that SGS does not
interfere with the kit, cells were permeabilized with a 2%
Triton-X 100 solution. The lysate was incubated with vari-
ous concentrations of SGS for 24 h. No difference was ob-
served for any of the control samples indicating that SGSs
do not interfere with the assay.
Flow cytometry
Viability was measured with flow cytometry (LSRII, BD
Biosciences, Franklin, NJ, USA) as described previously
[21]. Briefly, cell media was aspirated, and the adherent
cells were collected after trypsinization. Each sample was
washed and stained with annexin V-FITC and propidium
iodide (PI) without fixation or permeabilization. Annexin
V is a protein that binds to phosphatidylserine, which is
externalized in apoptotic cells. Propidium iodide fluo-
resces when it is bound to DNA in membrane-damaged
cells. Cells that were negative for both markers were cha-
racterized as viable. Approximately 50,000 events were
measured for each sample. Due to sample availability, only
one time point (24 h) was measured on one cell line
(SNU449) at two concentrations (10 and 100 μg/ml). As
such, these data have been placed in the Additional file 1.
Real-time optical bright-field microscopy
Hep3B cells were cultured in glass bottom (no. 1.5) 24-well
plates purchased from MatTek Corporation (Ashland,
MA, USA). After overnight incubation, the cells formed
non-confluent monolayers. The 24-well plate was placed
in an incubator enclosing a 1X81 Olympus microscope
(Center Valley, PA, USA) equipped with a DSU Confocal
Attachment and a ×60 oil immersion objective. The cells
were allowed to equilibrate with the incubator environ-
ment (37°C, 5% CO2) before adding pre-warmed SGSs
and acquiring images. Eight Z-plane images were acquired
with a gap of 1 μm every 15 min. A typical experiment
comprised of 10 to 15 waypoints. In-focus light from all
planes was merged and is represented in the still shots
and the movies. Hep3B cells with no exposure to SGS
were also imaged as a control.
Transmission/scanning electron microscopy
For transmission electron microscopy (TEM) imaging,
25,000 Hep3B or SNU449 cells were plated in 12-well
plates. After 24 h, the cells were exposed to the SGS at
10 μg/ml for 24 h. The media was removed, and cells
were washed twice with PBS. The cells were then
harvested after trypsinization and washed once more
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Fixative (BBC Biochemical, Seattle, WA, USA). Samples
were washed with 0.1% cacodylate-buffered tannic acid,
treated with 1% buffered osmium tetroxide, and stained
with 1% uranyl acetate. The samples were ethanol de-
hydrated and embedded in LX-112 medium. After
polymerization, the samples were cut with an UltraCut E
Microtome (Leica, IL, USA), double stained with uranyl
acetate/lead citrate in a Leica EM stainer, and imaged
with a JEM 1010 TEM (Jeol USA, Inc., Peabody, MA,
USA) at an accelerating voltage of 80 kV. Images were
acquired with an AMT Imaging System (Advanced Mi-
croscopy Techniques Corp., Woburn, MA, USA). For
SEM, the cells were prepared in a similar manner. The
dried samples were coated with a 35-nm-thick platinum
layer. Samples were imaged using a JSM 5900 scanning
electron microscope (JEOL USA, Inc.) equipped with a
backscatter electron detector and digital camera. The
beam energy was 5 kV.
Results and discussion
SGS characterization
As can be seen in Figure 1, AFM statistical analysis
showed the majority of SGSs (sample size 61) to be ap-
proximately 1.41 ± 0.08 μm in diameter with a height of
approximately 1.01 ± 0.02 nm, indicating mainly individ-
ualized SGSs [22,23]. In some instances, there was also
evidence of larger SGSs of diameter approximately 5.5
μm (Additional file 1: Figure S1). Raman spectra of the
initial graphite material and an SGS sample are depicted
in Additional file 1: Figure S2. According to previous
Raman studies [4], graphene can be identified by moni-Figure 1 AFM images of the SGSs. Left and right images depict complet
nm. Larger, more graphitic-like materials of diameters approximately 3 to 5toring the position of the 2D band, whereby sulfonation of
the phenyl groups and subsequent formation of the SGS
sodium salt lead to repulsive interactions between the
SO3− groups (to produce exfoliation), as evidenced by a
slight shift in the 2D peak in Additional file 1: Figure S2.
Functionalization by sulfonation has also been confirmed
by XPS and TGA, which is provided in Additional file 1:
Figures S3 and S4, respectively. Taken together, these data
characterize the SGS samples as being made up of both
individualized SGSs and stacked SGSs of diameters ran-
ging from 1.41 to 5.5 μm.
Cytotoxicity profiles of SGSs
MTT assay analysis over 5 days showed both a time- and
concentration-dependent cytotoxicity profile for both cell
lines. Control samples were also used in conjunction with
the in vitro samples to take into account an increase in
570-nm photon absorption due to the SGSs themselves,
which could obscure correct interpretation of the results.
As can be seen in Figure 2A, although the SNU449 and
Hep3B cell lines were approximately 80% to 90% viable
after 24 h upon exposure to SGS concentrations of 0.1 to
10 μg/ml, the highest concentration of 100 μg/ml resulted
in a drastic drop in viability to 60% and 20% for SNU449
and Hep3B cells, respectively. This decrease in viability
occurred over time until almost complete necrosis of cells
at 72 h. For lower concentrations, while the Hep3B cells
seem to tolerate SGS better, the SNU449 cells had the
greater viability (approximately 50%) for the 10 μg/ml
concentration after a 5-day period. The WST-1 results
shown in Figure 2B depict both a weak concentration-
and time-dependent cytotoxicity profile. The viability ofely exfoliated SGSs of diameter 1.41 ± 0.08 μm and height 1.01 ± 0.02
μm were also present in lower quantities (Additional file 1: Figure S1).
Figure 2 Cytotoxicity Data (MTT, WST-1, and LDH). MTT (A), WST-1 (B), and LDH (C) assays of SNU449 and Hep3B cancer cell lines. As a
function of time and SGS concentration.
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decreases to approximately 70% for the highest concentra-
tion. This is also similar for the SNU449 cells which show
a constant viability of approximately 90% to 135% for con-
centrations 0.1 to 10 μg/ml and a loss in viability down to
80% after a period of 48 to 72 h for the maximum concen-
tration of 100 μg/ml. Finally, the release of intracellular
LDH can provide evidence of plasma membrane damage.
Figure 2C shows minimal membrane damage as evidenced
by minimal LDH release in both cell lines after 72 h of ex-
posure to SGS for concentrations up to 100 μg/ml.
Previous work by Zhang et al. [18] demonstrated a simi-
lar MTT concentration-dependent viability profile with
neural phaeochromocytoma-derived PC12 cells exposed
to graphene synthesized via CVD (purified using a diluted
hydrochloric acid wash with sonication). They showed cellviability of approximately 40% after 24 h of exposure to
their graphene particles at a concentration of 100 μg/ml,
which is similar to MTT values seen in this work. In com-
parison, Chang et al. also demonstrated a concentration-
dependent profile which was however not time dependent
since they observed similar viability profiles at 24, 48, and
72 h [16].
Although the MTT and WST-1 profiles are generally
identical for time periods 24 to 72 h (with possibly the
exception of the WST-1 results which show a weak
time-dependent and concentration-dependent response),
the major difference is the drastic loss in viability for
concentrations of 100 μg/ml observed in the MTT assay.
This observation could be explained by interactions of
SGSs with insoluble MTT formazan crystals (formed
after the enzymatic reduction of MTT within the cells)
Corr et al. Nanoscale Research Letters 2013, 8:208 Page 6 of 10
http://www.nanoscalereslett.com/content/8/1/208which stabilize their structure and prevent them from
becoming solubilized by DMSO. This has already been
observed by Wörle-Knirsch et al. [24]. In their work,
they showed that single-walled carbon nanotubes (SWNTs)
were found to be non-toxic when using assays such as
LDH, annexin V, and PI staining, mitochondrial mem-
brane potential, as well as other tetrazolium salt-based
water-soluble assays such as WST-1, XTT, or INT. How-
ever, the MTT assay was the only assay which displayed
SWNTcytotoxicity.
In addition, real-time bright-field microscopy (Figure 3)
did not show any morphological features suggestive of
cytotoxicity, such as blebbing, membrane rupture, pyknosis,
or fragmentation, for concentrations 1 to 10 μg/ml. Also,
several cells were observed undergoing mitosis (data not
shown). These findings suggest that at these low concen-
trations, the sulfonation process affords protection to cells
against the cytotoxic effects of graphene, similar to the ob-
served protein corona-mediated mitigation of GO cyto-
toxicity recently published by Hu et al. [17]. However,
there was a drastic change in cell morphology for concen-
trations of 100 μg/ml which shows evidence of pyknosis
and fragmented, spindle-like cell features for the SNU449
cell lines. In these regard, we suggest that 10 μg/ml should
be the upper concentration limit when using SGSs for full
biocompatibility and that more work should be under-
taken to understand the exact death mechanism of SGSs
at concentrations >10 μg/ml. We initially sought to inves-
tigate this through the use of propidium iodide and
annexin V FITC staining with cell flow cytometry, but as
mentioned in the ‘Methods’ section, we could onlyFigure 3 Optical images of SNU449 cells exposed to SGSs for 72 h. Im
μg/ml concentrations.perform one time slot (24 h) with one cell line (SNU449)
at two concentrations (10 and 100 μg/ml).
Propidium iodide is a cell impermeable fluorophore that
can bind to the DNA of cells which have lost nuclear
and plasma membrane integrity. From our fluorescence-
activated cell sorting (FACS) analysis shown in Additional
file 1: Figure S5, we found that with an increasing concen-
tration of SGS nanoparticles, the intensity of positive PI-
stained cells increased from approximately 1.9% to 10.3%,
suggesting slight cell membrane structural damage, while
the majority of cells remain healthy and viable at appro-
ximately 93% ± 2.4%. Phosphatidylserine (PS) externali-
zation is an early event in the apoptosis cascade. Annexin
V binds to PS with high affinity. Our FACS analysis hence
also demonstrates that very few cells were annexin V posi-
tive 24 h after exposure to SGS which ruled out apoptosis
as a significant cell death mechanism, as was similarly
reported for GO materials [16,18].
Cellular internalization of SGSs
Figure 4 depicts high-resolution SEM images of both
SNU449 and Hep3B cancer cells after exposure to SGS at
a concentration of 10 μg/ml for 24 h. Control samples (no
SGSs) are shown in the Additional file 1: Figure S6. All
samples were first coated with a 35-nm layer of platinum
before imaging. The cells were approximately 10 to 25 μm
in diameter and heterogeneous in nature. Figure 4A
showed what is likely to be variability in surface coating of
the platinum layer. When comparing the left and right im-
ages of the SNU449 cellular structures in Figure 4A, the
left side has what looks like a thicker layer of platinum,ages depict control cells (no SGSs) (A) and 1 (B), 10 (C), and 100 (D)
Figure 4 SEM images of the interactions of completely exfoliated SGS and partially exfoliated SGS (i.e., graphite). With the surface of
SNU449 (A, B) and Hep3B (C to F) liver cancer cell lines.
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cent pseudopodia structures. Comparing Figure 4A and
Figure 4B, it can clearly be seen that a relatively large
structure is protruding out of a SNU449 cell in two loca-
tions. These structures appear to be graphite (i.e., multiple
stacked SGS) of thickness approximately 500 nm which
the cell has internalized. Figure 4C depicts another large
nanoplatelet of stacked SGS, which is effectively com-
pressing a Hep3B cell and deforming the cellularFigure 5 SGS Internalization within Hep3B cancer cells. TEM images of
cancer cells (A to F). Figure 4D,E,F is of the same cell.structure. Figure 4D and Figure 4E are the most interest-
ing figures since they display evidence of cellular internal-
ization, folding, and compartmentalization of SGS.
In Figure 4D, it appears as if the Hep3B cell is actively
internalizing multiple, stacked SGS of height approxi-
mately 35 nm, but is most likely a single SGS which looks
thicker due to the platinum layer. The folding phenome-
non is also evident in Figure 4E where folding of SGS can
be seen in the bottom left corner and bottom midsectioninternalized carbonaceous material and SGSs within Hep3B liver
Figure 6 TEM image of microtome cutting artifacts caused by
SGS inside a SNU449 cell. It is likely that some large chunks of
graphite and/or SGS have been dislodged from the transparent
region in the top right corner of the image.
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also evidence of slightly deformed SGS on top of the
cellular surface in the upper right-hand section. Finally,
Figure 4F depicts the images of both SGS deformation
and internalization of large pieces of graphitic materials.
The appearance of pseudopodia over the surface of the
SGS is indicated by the red arrows.
Cellular internalization of the SGS using microtome
high-resolution TEM was then investigated, as shown in
Figure 5. Uranyl acetate was used as a negative stainingFigure 7 Optical bright-field images of SGS internalization within Hep
diameters approximately 2 μm, indicated by red and blue arrows, are show
concentration 10 μg/ml. The two cells visible seem to be undergoing cell dagent. Although single-sheet graphene should appear
close to transparent in TEM imaging, we believe visua-
lization of the SGS in the TEM images is due to uranyl
ions binding to the functionalized graphene sheets
(which would result in a darker image) or that they are
stacked graphene layers which are reducing the optical
transparency. From the outset, we suspected that there
was some cellular internalization of submicron-sized
amorphous carbonaceous materials present in the initial
graphite material from which the SGS were obtained.
Evidence of this can be found in the Additional file 1:
Figure S1. Furthermore, Figure 5A,C indicates cellular
internalization of these materials since there is no evi-
dence of structural uniformity or stacking, which can
usually be seen for graphene by TEM at this resolution
[25]. However, Figure 5B clearly shows compartmen-
talization of SGS, and closer examination reveals a net-
work of lines (red arrows) throughout this structure,
which look exactly like the folded graphene sheets pre-
viously reported by A. K. Geim et al. [25]. A magnified view
of this key figure is shown in Additional file 1: Figure S7.
Figure 5D,F shows close up images of two areas of
Figure 5E to reveal a stained black circular particle
(Figure 5E) and a more transparent, slightly smaller, cir-
cular particle (Figure 5F). As these particles are of the
same diameter as the SGS previously characterized, they
are likely SGS that have internalized into the cell with-
out folding or compartmentalization. As previously in-
dicated, the large difference in contrast between these
two SGS structures could be due to uranyl ions binding
to the functionalized SGS or due to multiple stacked
graphene layers.
It should be noted that the cellular internalization of
large SGS caused artifacts in some instances during the3B cancer cells across a 17-h period. Two SGS particles of
n to be internalizing approximately 10 h after exposure to SGS of
ivision. (A to H) Time points at 10 to 17 h, in 1-h increments.
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where there is a large area of internalized SGS adjacent
to a completely transparent ‘hole’. This hole is most
likely caused by the microtome blade contacting the
SGS and removing the structure from the cellular cyto-
skeleton (thus leaving behind an SGS footprint). There is
also some evidence of this in Figure 5A where the car-
bonaceous NP seems to have been dislodged from its
initial position, leaving behind a transparent hole in the
left image. This result also serves as good evidence of
the cells’ ability to internalize relatively large pieces of
graphite yet still remain healthy.
Using real-time bright-field optical microscopy, we
could also track the internalization of SGSs in liver Hep3B
cells as a function of time (over a 17-h period). As can be
seen in Figure 7, when looking at snap shots from ap-
proximately 10 to 17 h, there were two large SGS (indi-
cated by red and blue arrows) which became attached to
the cell membrane and gradually internalized into the cell -
as is evidenced by the loss of resolution and blurred na-
ture of the SGS images. Furthermore, the cell retracted to
undergo mitosis once the trapped particles are internal-
ized. (Figure 7E,F,G,H, full movie also available in the
Additional file 2: Hep3B SGS movie and Additional file 3:
Hep3B control movie).
Given that graphene is thought to be the hardest material
known [3], it is counterintuitive to believe that liver carci-
noma cells are capable of folding and compartmentalizing
graphene sheets. However, if these sheets contained struc-
tural defects such as point defects, single vacancies, mul-
tiple vacancies, carbon adatoms, dislocation-like defects, or
edge defects, as extensively reviewed by Banhart et al. [26],
the cells may be able to fold the sheets, one at a time, along
these defect lines (in a ‘shedding nature’) and compart-
mentalize them within phagosomes or vesicles using rea-
sonably low-energy processes. The defect content of the
SGS, in relation to the starting graphite material, can be in-
dicated by the relative intensity of the Raman D band to G
band ratio, located at approximately 1,350 and 1,580 cm−1,
respectively [27]. Although the synthesis procedure and
Raman characterization shown in Additional file 1: Figure
S2 shows a weak D band enhancement after exfoliation
due to functionalization of the graphitic edges, it remains
unclear as to what defects, if any, are inherent to the
graphene nanoplatelets.
Conclusions
We have investigated the cytotoxicity and internalization
of highly exfoliated, water-soluble SGSs when exposed
in vitro to highly aggressive human liver cancer cells
(SNU449 and Hep3B). Both MTTand WST-1 colorimetric
assays displayed a similar concentration- and time-
dependent cytotoxicity profile for concentrations of 0.1 to
10 μg/ml. These trends were also evident from LDHobservations. However, the SGSs seemed to be toxic to
both cell lines at the highest concentration of 100 μg/ml.
We have also observed an interesting cellular internaliza-
tion phenomenon for graphene materials for the first time.
The cancer cells were capable of internalizing relatively
large SGSs with diameters comparable to the cells them-
selves as well as smaller SGS having heights indicative of
single graphene sheets. Although not conclusive, there is
evidence to suggest that due to graphene structural de-
fects, the cancer cells are also able to actively fold and
compartmentalize these sheets. We speculate that the
findings reported here may encourage the development of
SGSs for applications in drug delivery, medical imaging,
and even hyperthermic cancer therapy by NIR and/or
radio frequency heating. To date, such applications have
been explored for more rigid carbon nanostructures such
as fullerenes [28] and nanotubes [29-32], but a non-toxic,
more flexible (foldable), and larger surface-area material as
provided by graphene offers an alternative design strategy.
Additional files
Additional file 1: Supplementary information. Figure S1: AFM images
of SGSs, Figure S2: Raman spectra, Figure S3: XPS spectra, Figure S4: TGA
of completely exfoliated SGSs, Figure S5: FACS analysis, Figure S6: SEM
image, and Figure S7: magnified view of Figure 5B (maintext).
Additional file 2: Hep3B SGS movie. Movie sequence of SGS
internalization over a 17-h time period. Cell lines are Hep3B.
Additional file 3: Hep3B control movie. Movie sequence of Hep3B
control (no SGS exposure) across a 17-h time period.
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